WallStreetZenWallStreetZen

NASDAQ: STLN
Starling Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for STLN

Based on 4 analysts offering 12 month price targets for Starling Oncology Inc

Min Forecast
$9.00+107.37%
Avg Forecast
$9.75+124.65%
Max Forecast
$10.00+130.41%

Should I buy or sell STLN stock?

Based on 4 analysts offering ratings for Starling Oncology Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although STLN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates STLN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their STLN stock forecasts and price targets.

STLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-09
lockedlocked$00.00+00.00%2026-11-06
lockedlocked$00.00+00.00%2026-11-06
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-07-06

1 of 1

Forecast return on equity

Is STLN forecast to generate an efficient return?

Company
-25.06%
Industry
-44.3%
Market
144.04%
STLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STLN forecast to generate an efficient return on assets?

Company
4.99%
Industry
9.57%
STLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STLN earnings per share forecast

What is STLN's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
-$0.02
Avg 3 year Forecast
$0.09

STLN revenue forecast

What is STLN's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$673.0M+8.47%
Avg 2 year Forecast
$899.7M+45.01%
Avg 3 year Forecast
$1.2B+91.31%
STLN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STLN revenue growth forecast

How is STLN forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
21.6%
Industry
3.31%
Market
12.76%
STLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STLN vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
STLN$4.34$9.75+124.65%Strong Buy
MCTA$29.36N/AN/A
SRTA$6.02N/AN/A
AUNA$4.60$5.00+8.70%Hold
CYH$2.17$2.51+15.58%Sell
View Top Medical Care Facility Stocks

Starling Oncology Stock Forecast FAQ

Is Starling Oncology Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: STLN) stock is to Strong Buy STLN stock.

Out of 4 analysts, 3 (75%) are recommending STLN as a Strong Buy, 1 (25%) are recommending STLN as a Buy, 0 (0%) are recommending STLN as a Hold, 0 (0%) are recommending STLN as a Sell, and 0 (0%) are recommending STLN as a Strong Sell.

If you're new to stock investing, here's how to buy Starling Oncology stock.

What is STLN's earnings growth forecast for 2026-2028?

(NASDAQ: STLN) Starling Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 3.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.75%.

Starling Oncology's earnings in 2026 is -$40,355,000.On average, 7 Wall Street analysts forecast STLN's earnings for 2026 to be -$16,910,112, with the lowest STLN earnings forecast at -$20,989,753, and the highest STLN earnings forecast at -$11,779,963. On average, 6 Wall Street analysts forecast STLN's earnings for 2027 to be -$1,560,463, with the lowest STLN earnings forecast at -$10,994,632, and the highest STLN earnings forecast at $10,709,058.

In 2028, STLN is forecast to generate $9,362,776 in earnings, with the lowest earnings forecast at $8,995,608 and the highest earnings forecast at $9,638,152.

What is STLN's revenue growth forecast for 2026-2028?

(NASDAQ: STLN) Starling Oncology's forecast annual revenue growth rate of 21.6% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.31%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.76%.

Starling Oncology's revenue in 2026 is $620,447,000.On average, 7 Wall Street analysts forecast STLN's revenue for 2026 to be $68,641,998,972, with the lowest STLN revenue forecast at $65,438,460,909, and the highest STLN revenue forecast at $71,750,685,384. On average, 6 Wall Street analysts forecast STLN's revenue for 2027 to be $91,763,364,113, with the lowest STLN revenue forecast at $86,960,606,793, and the highest STLN revenue forecast at $95,653,301,769.

In 2028, STLN is forecast to generate $121,063,345,488 in revenue, with the lowest revenue forecast at $116,269,767,360 and the highest revenue forecast at $124,633,031,328.

What is STLN's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: STLN) forecast ROA is 4.99%, which is lower than the forecast US Medical Care Facilities industry average of 9.57%.

What is STLN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year STLN price target, the average STLN price target is $9.75, with the highest STLN stock price forecast at $10.00 and the lowest STLN stock price forecast at $9.00.

On average, Wall Street analysts predict that Starling Oncology's share price could reach $9.75 by Nov 9, 2027. The average Starling Oncology stock price prediction forecasts a potential upside of 124.65% from the current STLN share price of $4.34.

What is STLN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: STLN) Starling Oncology's current Earnings Per Share (EPS) is -$50,304.74. On average, analysts forecast that STLN's EPS will be -$0.17 for 2026, with the lowest EPS forecast at -$0.21, and the highest EPS forecast at -$0.12. On average, analysts forecast that STLN's EPS will be -$0.02 for 2027, with the lowest EPS forecast at -$0.11, and the highest EPS forecast at $0.11. In 2028, STLN's EPS is forecast to hit $0.09 (min: $0.09, max: $0.09).

What is STLN's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: STLN) forecast ROE is -25.06%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.